Education, Research, Partnerships
Our Vision
An emphasis on quality, compliance and patient-driven science
Committed to enabling innovative biopharmaceutical education, global regulatory convergence, industry partnerships and use-inspired research for the benefit of patients worldwide.
Committed to enabling innovative biopharmaceutical education, global regulatory convergence, industry partnerships and use-inspired research for the benefit of patients worldwide.
A Unique Offering for Scientific and Medical Stakeholders
BATL is the only source for a one-place partnership focused on collaborations that unite various scientific stakeholders across the globe. Our unique offerings meet the needs of multiple and diverse scientific and medical stakeholders, from early discovery and development in industry to experiential training, from global regulatory convergence to use-inspired research.
BATL is proudly recognized by the Asia-Pacific Economic Cooperation (APEC), the International Council for Harmonisation (ICH), the Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Health Organization (WHO) as a neutral, global facilitator of collaboration between academia, industry, and government toward regulatory convergence.
BATL is the only source for a one-place partnership focused on collaborations that unite various scientific stakeholders across the globe. Our unique offerings meet the needs of multiple and diverse scientific and medical stakeholders, from early discovery and development in industry to experiential training, from global regulatory convergence to use-inspired research.
BATL is proudly recognized by the Asia-Pacific Economic Cooperation (APEC), the International Council for Harmonisation (ICH), the Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Health Organization (WHO) as a neutral, global facilitator of collaboration between academia, industry, and government toward regulatory convergence.
Research
State of the art labs
BATL is responding to industry’s needs to do research in a way that will eventually be used in the real world, what we call use-inspired research. Specific projects in analytical improvements, operational improvements, process improvements, and standard validation are at the core of our research programs. For example, research collaborations exist with the United States Pharmacopeia (USP) for standards validation, with Thermo Fisher for analytical (mass spectrometry) application validation, and others. To do this, we collaborate with our partners to customize a research program to meet their industry demands.
“
Our worldwide presence provides a unique opportunity for BATL to meet the most pressing needs of global biopharmaceutical organizations, from regulatory agencies to industry and academia.
Jared R. Auclair
Director of BATL
News
People have been talking about us.
3 Key Quality Trends To Watch In The Biopharma World
Biopharma and biotech professionals operate in an intensely competitive and highly regulated sphere. And as the direction, impact, and significance of life science quality continues to shift, 3 emerging trends will define the industry’s near-term future.
Seeing the Future: Microsoft Partnership allows Professor Jared Auclair to bring Virtual Reality to the Classroom
The technology of the future is here—Microsoft’s new mixed reality device, the HoloLens, is in the palms of Northeastern’s hands and Professor Jared Auclair is testing its power in the classroom and beyond.
Jared Auclair gives NBC News an inside look at Northeastern's COVID Testing Center
Northeastern University’s coronavirus testing lab in Burlington, Massachusetts, gave NBC10 Boston an inside look at how thousands of samples are processed daily.
Network
Accelerate discovery through the power of Networks
BATL’s growing global network comprises of recognized scientific and economic agencies fueling collaborative drug and biologics discovery. As BATL grows, our innovation grows, with our impressive network of faculty and practitioner innovators supporting BATL’s Education, Partnerships and Research worldwide.
